These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30661286)

  • 21. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
    J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study.
    Donzé J; Rodondi N; Waeber G; Monney P; Cornuz J; Aujesky D
    Am J Med; 2012 Nov; 125(11):1095-102. PubMed ID: 22939362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study.
    Palla A; Ribas C; Rossi G; Pepe P; Marconi L; Prandoni P
    J Thromb Haemost; 2010 Jan; 8(1):68-74. PubMed ID: 19817998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy.
    Jiménez D; Yusen RD; Otero R; Uresandi F; Nauffal D; Laserna E; Conget F; Oribe M; Cabezudo MA; Díaz G
    Chest; 2007 Jul; 132(1):24-30. PubMed ID: 17625081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials.
    Laporte S; Chapelle C; Bertoletti L; Ollier E; Zufferey P; Lega JC; Merah A; Décousus H; Schulman S; Meyer G; Cucherat M; Mismetti P
    J Thromb Haemost; 2017 Aug; 15(8):1547-1558. PubMed ID: 28544422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
    Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
    JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of the HAS-BLED and ATRIA scores for the risk of bleeding in patients aged 75 and over receiving vitamin K antagonist (VKA) therapy and educated VKA-management].
    Soave C; Chidlovskii E; Lebelhomme A; Gaboreau Y; Pernod G; Bosson JL; Couturier P
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Sep; 13(3):279-88. PubMed ID: 26395301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.
    Fermann GJ; Erkens PM; Prins MH; Wells PS; Pap ÁF; Lensing AW
    Acad Emerg Med; 2015 Mar; 22(3):299-307. PubMed ID: 25716463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
    Klok FA; Dzikowska-Diduch O; Kostrubiec M; Vliegen HW; Pruszczyk P; Hasenfuß G; Huisman MV; Konstantinides S; Lankeit M
    J Thromb Haemost; 2016 Jan; 14(1):121-8. PubMed ID: 26509468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.
    van Rein N; Biedermann JS; van der Meer FJM; Cannegieter SC; Wiersma N; Vermaas HW; Reitsma PH; Kruip MJHA; Lijfering WM
    J Thromb Haemost; 2017 Jul; 15(7):1386-1391. PubMed ID: 28440008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk assessment of pulmonary embolism with the GRACE risk score.
    Paiva LV; Providencia RC; Barra SN; Faustino AC; Botelho AM; Marques AL
    Am J Cardiol; 2013 Feb; 111(3):425-31. PubMed ID: 23168283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the IMPROVE bleeding risk score in Chinese medical patients during hospitalization: Findings from the dissolve-2 study.
    Zhang Z; Zhai Z; Li W; Qin X; Qu J; Shi Y; Xu R; Xu Y; Wang C;
    Lancet Reg Health West Pac; 2020 Nov; 4():100054. PubMed ID: 34327391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.
    Peris M; Jiménez D; Maestre A; Font C; Tafur AJ; Mazzolai L; Xifre B; Skride A; Dentali F; Monreal M;
    Eur Respir J; 2016 Nov; 48(5):1360-1368. PubMed ID: 27660517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
    Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
    BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism: a meta-analysis of randomized controlled trials.
    Chen H; Ren C; Chen H
    Respir Care; 2014 Dec; 59(12):1880-7. PubMed ID: 25269681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major bleeding in patients with pulmonary embolism presenting with syncope.
    Maestre A; Escribano JC; Lobo JL; Jara-Palomares L; Jiménez D; Bikdeli B; Armestar F; Bura-Riviere A; Lorenzo A; Monreal M;
    Eur J Clin Invest; 2022 Jul; 52(7):e13774. PubMed ID: 35302666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.
    Klok FA; Ageno W; Barco S; Binder H; Brenner B; Duerschmied D; Empen K; Faggiano P; Ficker JH; Galiè N; Ghuysen A; Held M; Heydenreich N; Huisman MV; Jiménez D; Kozak M; Lang IM; Lankeit M; Münzel T; Petris A; Pruszczyk P; Quitzau K; Schellong S; Schmidt KH; Stefanovic BS; Verschuren F; Wolf-Puetz A; Meyer G; Konstantinides SV;
    Thromb Haemost; 2017 Dec; 117(12):2425-2434. PubMed ID: 29212130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
    Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
    Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.